Literature DB >> 13400852

Malignant carcinoid tumours.

R S STACEY.   

Abstract

Entities:  

Keywords:  ARGENTAFFINOMA/metabolism; GASTROINTESTINAL SYSTEM/neoplasms; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1957        PMID: 13400852      PMCID: PMC1888990     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  11 in total

1.  Determination of 5-hydroxy-indole-acetic acid in urine; and its excretion in patients with malignant carcinoids.

Authors:  A HANSON; F SERIN
Journal:  Lancet       Date:  1955-12-31       Impact factor: 79.321

2.  5-Hydroxytryptamine in normal human platelets.

Authors:  R M HARDISTY; R S STACEY
Journal:  J Physiol       Date:  1955-12-29       Impact factor: 5.182

3.  Paper chromatography of urinary indoles.

Authors:  J B JEPSON
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

4.  Humoral effects of metastasising carcinoid tumours.

Authors:  P J SNOW; J E LENNARD-JONES; G CURZON; R S STACEY
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

5.  A rapid chromatographic test for high urinary excretion of 5-hydroxy-indole-acetic acid and 5-hydroxytryptamine.

Authors:  G CURZON
Journal:  Lancet       Date:  1955-12-31       Impact factor: 79.321

6.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

Authors:  S UDENFRIEND; E TITUS; H WEISSBACH
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

7.  [Detection of 5-hydroxytryptamine in urine].

Authors:  F LEMBECK; K NEUHOLD
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1955

8.  Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxy-tryptamine in blood and urine.

Authors:  B PERNOW; H SILWER; J WALDENSTROM
Journal:  Acta Med Scand       Date:  1956-12-08

9.  Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis.

Authors:  P S MACFARLANE; C E DALGLIESH; R W DUTTON; B LENNOX; L M NYHUS; A N SMITH
Journal:  Scott Med J       Date:  1956-04       Impact factor: 0.729

10.  Pharmacology of indole-alkylamines.

Authors:  V ERSPAMER
Journal:  Pharmacol Rev       Date:  1954-12       Impact factor: 25.468

View more
  5 in total

1.  Observations on the occurrence and significance of serotonin in carcinoid tumors.

Authors:  R B DAVIS
Journal:  Am J Pathol       Date:  1962-12       Impact factor: 4.307

2.  Metastatic argentaffinoma secreting 5-hydroxytryptamine in a patient with a patent foramen ovale.

Authors:  H R WOLFE; A DAVIES; A P MATHIAS; M SCHACHTER
Journal:  Br Med J       Date:  1960-03-26

3.  Metastasizing carcinoid; with a case report of the carcinoid syndrome.

Authors:  E J BEATON
Journal:  Can Med Assoc J       Date:  1959-02-15       Impact factor: 8.262

4.  Serotonin release from carcinoid tumours.

Authors:  W P JONES
Journal:  Can Anaesth Soc J       Date:  1962-01

5.  Chemotherapy for the carcinoid syndrome.

Authors:  A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.